The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Compliance with Results Reporting at ClinicalTrials.gov
Open accessAbstract
BACKGROUND: The Food and Drug Administration Amendments Act (FDAAA) mandates timely reporting of results of applicable clinical trials to ClinicalTrials.gov. We characterized the proportion of applicable clinical trials with publicly available results and determined independent factors associated with the reporting of results. METHODS: Using an algorithm based on input from the National Library of Medicine, we identified trials that were likely to be subject to FDAAA provisions (highly likely applicable clinical trials, or HLACTs) from 2008 through 2013. We determined the proportion of HLACTs that reported results within the 12-month interval mandated by the FDAAA or at any time during the 5-year study period. We used regression models to examine characteristics associated with reporting at 12 months and throughout the 5-year study period. RESULTS: From all the trials at ClinicalTrials.gov, we identified 13,327 HLACTs that were terminated or completed from January 1, 2008, through August 31, 2012. Of these trials, 77.4% were classified as drug trials. A total of 36.9% of the trials were phase 2 studies, and 23.4% were phase 3 studies; 65.6% were funded by industry. Only 13.4% of trials reported summary results within 12 months after trial completion, whereas 38.3% reported results at any time up to September 27, 2013. Timely reporting was independently associated with factors such as FDA oversight, a later trial phase, and industry funding. A sample review suggested that 45% of industry-funded trials were not required to report results, as compared with 6% of trials funded by the National Institutes of Health (NIH) and 9% of trials that were funded by other government or academic institutions. CONCLUSIONS: Despite ethical and legal obligations to disclose findings promptly, most HLACTs did not report results to ClinicalTrials.gov in a timely fashion during the study period. Industry-funded trials adhered to legal obligations more often than did trials funded by the NIH or other government or academic institutions. (Funded by the Clinical Trials Transformation Initiative and the NIH.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This data may not have been published in any other location, making study registries a critical component of an information strategy, though timely reporting remains a challenge [58, 59].”
From PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews (2021) · cites this paper as [58]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This data may not have been published in any other location, making study registries a critical component of an information strategy, though timely reporting remains a challenge [58, 59].”
From PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews (2021) · cites this paper as [58]
The cited source says what the claim attributes to it.
In the citing paper
“This data may not have been published in any other location, making study registries a critical component of an information strategy, though timely reporting remains a challenge [58, 59].”
From PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews (2021) · cites this paper as [58]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675
What Makes Clinical Research Ethical?
Emanuel, E. J. (2000) · JAMA · doi:10.1001/jama.283.20.2701 · Cited by 2,710
Selective publication of antidepressant trials and its influence on apparent efficacy
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa065779 · Cited by 2,435
The ClinicalTrials.gov Results Database — Update and Key Issues
Zarin, D. A., Tse, T., Williams, R. J., Califf, R. M., & Ide, N. C. (2011) · New England Journal of Medicine · doi:10.1056/nejmsa1012065 · Cited by 838
Self-citationCharacteristics of Clinical Trials Registered in ClinicalTrials.gov, 2007-2010
Califf, R. M. (2012) · JAMA · doi:10.1001/jama.2012.3424 · Cited by 516
Self-citationClinical Trial Registration — Looking Back and Moving Ahead
Laine, C. M., Horton, R. C., DeAngelis, C. D., Drazen, J. M., Frizelle, F., Godlee, F., Haug, C. J., Hébert, P. C., Kotzin, S., Marušić, A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejme078110 · Cited by 320
Prayle, A., Hurley, M. N., & Smyth, A. R. (2012) · BMJ · doi:10.1136/bmj.d7373 · Cited by 299
Disclosing Individual Results of Clinical Research: Implications of Respect for Participants
Shalowitz, D. I., & Miller, F. G. (2005) · JAMA · doi:10.1001/jama.294.6.737 · Cited by 265
Tasneem, A., Aberle, L. H., Ananth, H., Chakraborty, S., Chiswell, K., McCourt, B. J., & Pietrobon, R. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033677 · Cited by 176
Self-citationLaine, C. M., Horton, R. C., DeAngelis, C. D., Drazen, J. M., Frizelle, F., Godlee, F., Haug, C. J., Hébert, P. C., Kotzin, S., Marušić, A., et al. (2007) · JAMA · doi:10.1001/jama.298.1.jed70037 · Cited by 135
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–381 of 381
Automated Generation of Core Outcome Measures for Clinical Trials
Elghafari, A., & Finkelstein, J. (2021) · Studies in health technology and informatics · doi:10.3233/shti210784 · Cited by 1
Howard, J. (2018) · Springer eBooks · doi:10.1007/978-3-319-93224-8_30 · Cited by 1
The borderline with medical devices in the current Spanish legal framework
Antich-Isern, P., & Blanco, J. A. (2022) · Anales de la Real Academia Nacional de Farmacia · doi:10.53519/analesranf.2022.88.02.06 · Cited by 1
Controversies with Clinical Trial Regulations in Low- and Middle-Income Countries
Rake, B. (2022) · Springer eBooks · doi:10.1007/978-3-030-99680-2_23 · Cited by 1
Mao, L., Wang, L., & Lv, D.-M. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1167278 · Cited by 1
Use Cases for Secure and Trusted Granular Data Sharing Among Disparate Databases
DeFranco, J. F., Ferraiolo, D. F., Roberts, J. D., & Kuhn, D. R. (2024) · IEEE reliability magazine · doi:10.1109/mrl.2024.3352570 · Cited by 1
Kendall, N. A. S., Pennington, Z. A., Hamouda, A. M., Cwajna, M., Ghozy, S. A., Kallmes, D. F., & Elder, B. D. (2025) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2025.111148 · Cited by 1
Compliance on Mandatory Data Reporting in Registered Obstetrics Trials
Evans, M. E., Athale, A., Jawhar, O., Wright, M. R., Bryant, K., Vassar, M. B., & Checketts, J. X. (2018) · American Journal of Perinatology · doi:10.1055/s-0038-1642620 · Cited by 1
An Institutional Program to Increase Compliance with Clinicaltrials.gov Requirements
Kelly-Pumarol, I., & Andrews, J. E. (2018) · Therapeutic Innovation & Regulatory Science · doi:10.1177/2168479018778284 · Cited by 1
Zeitler, E. P., Gasperetti, A., Dodge, S. E., Cooper, L. B., & Kaplan, A. (2021) · Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease · doi:10.1161/jaha.120.019513 · Cited by 1
Discoverability of information on clinical trial data-sharing platforms
Wilson, P., & Huser, V. (2021) · Journal of the Medical Library Association JMLA · doi:10.5195/jmla.2021.992 · Cited by 1
Lampropoulou, M., Grammatikopoulou, M. G., Theodoridis, X., Katsaridis, S., Bobora, D., Patsatsi, A., Haidich, A., & Goulis, D. G. (2022) · Dietetics · doi:10.3390/dietetics1020012 · Cited by 1
Sultana, J., Camilleri, N., Crisafulli, S., Borg, J. J., Spagnol, S., Tillati, S., & Borg, J. (2023) · Therapeutic Advances in Rare Disease · doi:10.1177/26330040231213888 · Cited by 2
Editor's Commentary: The Letter to the Other Editor
Heinemann, M. (2016) · The Thoracic and Cardiovascular Surgeon · doi:10.1055/s-0036-1584885 · Cited by 1
Rx for Innovation: A path forward for us all
Anderson, M. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aam7203 · Cited by 1
Self-citationToo few trials or too few reported trials?
Viteri-García, A. A., DeVito, N., & Goldacre, B. M. (2018) · Evidence-Based Dentistry · doi:10.1038/sj.ebd.6401317 · Cited by 2
Essays in the Economics of Health and Innovation
Kao, J. L. (2019) · Digital Access to Scholarship at Harvard (DASH) (Harvard University) · Cited by 1
Towards More Flexible False Positive Control in Phase III Randomized Clinical TrialsPreprint
Shen, C., & Li, X. (2019) · arXiv (Cornell University) · doi:10.48550/arxiv.1902.08229 · Cited by 1
Gamertsfelder, E., Delgado-Figueroa, N., Keestra, S., Silva, A., Borana, R., Siebert, M., & Brückner, T. (2023) · medRxiv · doi:10.1101/2023.04.03.23288059 · Cited by 1
Rennie, D., & Murphy, C. (2015) · Wiley StatsRef: Statistics Reference Online · doi:10.1002/9781118445112.stat06923.pub2
Results of all clinical trials should be posted within a year, says WHO
Wise, J. (2015) · BMJ · doi:10.1136/bmj.h1987
The need for even further progress with clinical trial data sharing efforts: patients are waiting
Morris, S. A., Childers, K., Berlin, J. A., & Waldstreicher, J. (2015) · Clinical Investigation · doi:10.4155/cli.15.22
Competing interests in continuing medical education – what should accreditors do?
Griebenow, R. (2016) · Continuing Cardiology Education · doi:10.1002/cce2.15
Trial-Results Reporting and Academic Medical Centers
Peterson, E. D. (2015)
Self-citationEnvoi—An Appraisal of Targeted Therapies for Head and Neck Cancer
Nagao, T., & Warnakulasuriya, S. (2017) · Springer eBooks · doi:10.1007/978-94-024-1084-6_10
Piech, C. T., Lefèbvre, P., & Pike, C. T. (2017) · Springer eBooks · doi:10.1007/978-981-10-3262-2_5
Trial Registration and Public Access to Data
Laks, S., Kim, L. T., & Lucero, Y. (2017) · Springer eBooks · doi:10.1007/978-3-319-53877-8_42
Tiwari, A., Joshi, M., Gandhi, S., Bandopadhyay, S., & Tekade, R. K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814421-3.00017-8
FDA proposes stiff fines for failing to report clinical trials
Reardon, S. (2018) · Nature · doi:10.1038/d41586-018-06801-7
Medizinische Autorität und Interessenkonflikt: Content is King
Herold, N. (2018) · Springer eBooks · doi:10.1007/978-3-662-57416-4_10
Bazac, A. (2018) · Journal of Contemporary Central and Eastern Europe · doi:10.1080/25739638.2018.1511110
A Risk-Based Paradigm of Biomarkers in Clinical Trials
Parker, J. L., Domazetoski, E., Bureau, M., Lopes, G. D. L., Jr., Kuzulugil, S. S., & Mitsakakis, N. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813539-6.00021-3
Transparency and Data Sharing in Clinical Research and Big Pharma
Miller, J. E. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108658867.028
Clinical trials of neurointervention : 2007–2018
Saber, H., Jadhav, A. P., Rajah, G. B., Narayanan, S., Sheth, S. A., Liebeskind, D. S., & Somai, M. M. (2019) · Journal of NeuroInterventional Surgery · doi:10.1136/neurintsurg-2019-015117
Chalut, F., Chalut, F., & LeLorier, J. (2019) · Journal of Clinical Cardiology and Cardiovascular Therapy · doi:10.31546/jcccvt.1005
Gross, N. J. (2015) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.2.4.2015.0163
Urologische Forschung in Deutschland
Neuberger, M., Weiß, C., Westhoff, N., Worst, T. S., Michel, M. S., & von Hardenberg, J. (2020) · Der Urologe · doi:10.1007/s00120-020-01206-9
Randomized Controlled Trials: Informing Clinical Practice for Traumatically Injured Patients
Reitz, K. M., Althouse, A. D., & Sperry, J. L. (2020) · Springer eBooks · doi:10.1007/978-3-030-53606-0_40
The Technology of Biotechnology and Big Data in Medicine Development
Perakslis, E. D., & Stanley, M. (2021) · Oxford University Press eBooks · doi:10.1093/oso/9780197503133.003.0006
COVID-19 challenges in clinical trials
Panchatcharam, M., & Mukku, L. S. (2021) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20212092
Mair, N. K., Gottowik, J., Rodriguez‐Esteban, R., & Seabrook, T. J. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.03.471055
Statistical Use and Misuse in Scientific Publications
Hoffman, J. I. E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817084-7.00002-4
How to encourage trial reporting
(2016) · Nature Medicine · doi:10.1038/nm.4167
Oh, S., Moon, S. K., & Lee, K.-R. (2020) · doi:10.26226/morressier.5f0c7d3058e581e69b05d0d9
Kao, J. (2021) · Social Science Research Network · doi:10.2139/ssrn.3883041 · Cited by 5
Mishra, B., Agarwal, A., Nilima, N., Srivastava, M. V. P., & Vishnu, V. Y. (2022) · Acta Neurologica Scandinavica · doi:10.1111/ane.13669 · Cited by 1
The applicability and utilization of systematic reviews for clinical practice
Lindsley, K. B. (2022) · Utrecht University Repository (Utrecht University) · doi:10.33540/1513
Development Pattern of Medical Device Technology and Regulatory Evolution of Cataract Treatment
Kim, H., Jeong, H., & Shin, K. (2023) · Healthcare · doi:10.3390/healthcare11040453
Keim‐Malpass, J., Blair, L. M., Doede, A. L., Chu, C., Graham, C., & Petersen, W. C. (2023) · Cancer Care Research Online · doi:10.1097/cr9.0000000000000039
Osteopathie und evidenzbasierte Medizin, Teil 2: Kritik an der EBM
Luthin, D. (2024) · DO - Deutsche Zeitschrift für Osteopathie · doi:10.1055/a-2220-8344
Zhao, L., Qu, Y., Zhang, Y., Zou, Z., Lu, J., Wang, Z., Li, B., & Fang, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39408
Appendix 2: Initiatives to Improve the Quality of Research
Crombie, I. (2021) · Wiley eBooks · doi:10.1002/9781394322183.app2
Rethlefsen, M. L. (2024) · Research Publications (Maastricht University) · doi:10.26481/dis.20250121mr
Vazquez, E., Ross, J. S., Gross, C. P., Childers, K., Bamford, S., Ritchie, J. D., Waldstreicher, J., Krumholz, H. M., & Wallach, J. D. (2024) · Clinical Trials · doi:10.1177/17407745241304355
Federated Learning with Neural Graphical Models
Chajewska, U., & Shrivastava, H. (2024) · Communications in computer and information science · doi:10.1007/978-3-031-74643-7_32
Assessing compliance to reporting mandates in glioblastoma-related clinical trials
Kendall, N. A. S., Rechberger, J. S., Hamouda, A. M., Cwajna, M., Ghozy, S. A., Arumaithurai, K., & Kallmes, D. F. (2025) · PLoS ONE · doi:10.1371/journal.pone.0323109
The impact of discontinuation and non-publishing of osteoporosis clinical trials
Kennington, D., Simonsen, A., Shae, W., & Satterwhite, C. L. (2025) · Journal of Osteopathic Medicine · doi:10.1515/jom-2025-0183
Rethlefsen, M., Kirtley, S., Waffenschmidt, S., Ayala, A. P., Moher, D., Page, M. J., & Koffel, J. B. (2021) · Figshare · doi:10.6084/m9.figshare.13646921
Jurić, D., Zlatin, M., & Marušić, A. (2022) · Figshare · doi:10.6084/m9.figshare.19695681
Itani, M., Livsey, T., Keefer, K., Elghzali, A., Sherry, R., Harris, T., Archer, D. B., Ford, A. I., & Vassar, M. (2026) · BMC Urology · doi:10.1186/s12894-026-02077-6
Lorenzo, G. D., Melluso, M., & Seidita, A. (2026) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.70382
Women Are Unequally Represented Among Clinical Trial Leadership by Orthopaedic Subspecialty
Mao, E., Glenn, E. R., Ryu, D., Chang, B., LaPorte, D. M., & Aiyer, A. A. (2026) · Clinical Orthopaedics and Related Research · doi:10.1097/corr.0000000000003848
Alkhawaldeh, K. M., Thorpe, S., Cho, S., Miller, A. A., Alleyne, M. M., Jones, J. M., Beaupin, L. K., Gupta, A. K., & Metts, J. L. (2026) · Children · doi:10.3390/children13040455
Transparency and the Allocation of Control Rights: Evidence from the 2017 FDA Disclosure MandatePreprint
Martin, X., & Gu, P. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.6516799
Arzola, A., Sonis, S. T., & Villa, A. (2026) · Oral Diseases · doi:10.1111/odi.70354
Lytras, M. D., Alzahrani, B., Almabadi, R., Abukammas, S., Alsaywid, B. S., & Lytra, C.-C. (. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27743-6.00008-7
Martinić-Cezar, I. J., Pranić, S. M., Tavra, A., & Marušić, A. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15103981
Chimakurthy, A., Susarla, V., CHAUDHARY, J. K., & Desai, O. (2026) · BMC Neurology · doi:10.1186/s12883-026-05327-0
Richardson, M. T., Barry, D., Steinberg, J. R., Holder, K., Thirunavu, V. M., Zhang, N., Turner, B. E., Magnani, C. J., Young, A. M. P., Lu, C. F., et al. (2026) · Gynecologic Oncology · doi:10.1016/j.ygyno.2026.08.015
TrialScout links published results to trial registrations using a large language model
Ahnström, L., Brückner, T., Aspromonti, D. A., Caquelin, L., Cummins, J. D., DeVito, N., Axfors, C., Ioannidis, J. P. A., & Nilsonne, G. (2026) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2026.112484
Optimizing Development of Plain Language Summaries of Clinical Trial Results
Doralt, J., Keohane, B., McGilvray, A., Pobinger, D., & Pavlova, B. G. (2026) · HLRP Health Literacy Research and Practice · doi:10.3928/24748307-20260410-02
Wali, S. M., Almuzaini, O. K., Alsheikh, E. O., Abduljawad, S. A., Habib, A. S., & Almarshad, S. A. (2026) · Journal of Disability Research · doi:10.57197/jdr-2026-0968
Wang, J., Wu, J., Yang, Z., Pei, Y., Meng, F., & Han, J. (2026) · Clinical Otolaryngology · doi:10.1111/coa.70174
Metadata
- Authors
- Anderson, M. L., Chiswell, K., Peterson, E. D., Tasneem, A., Topping, J., & Califf, R. M.
- Affiliations
- Duke University (US)
- Duke Medical Center (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-03-12
- Volume
- 372
- Issue
- 11
- Pages
- 1031-1039
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC4508873
- OpenAlex
- W1963526469
- Cited by
- 380
- References
- 19
- Citations by year
- 2026: 21 · 2025: 14 · 2024: 17 · 2023: 18 · 2022: 36 · 2021: 33 · 2020: 37 · 2019: 28 · 2018: 51 · 2017: 38 · 2016: 50 · 2015: 36
- FWCI
- 68.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- public-domain
- Locations
- New England Journal of Medicine (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DukeSpace (Duke University) (submittedVersion)
- Funders
- National Institutes of Health
- U.S. National Library of Medicine
- Duke Clinical Research Institute
- National Center for Complementary and Integrative Health (U54AT007748)
- Topics
- Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare
- Social Sciences › Library and Information Sciences › Academic Publishing and Open Access
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Keywords
- ClinicalTrials.gov, result reporting, clinical trial transparency, regulatory compliance, industry-funded trials, trial phase, FDA oversight, drug trials
- MeSH terms
- Algorithms, Clinical Trials as Topic, Drug Industry, Humans, National Library of Medicine (U.S.), Registries, Research Support as Topic, United States, United States Food and Drug Administration, Proportional Hazards Models, Databases, Factual, Disclosure, Government Regulation, Mandatory Programs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
